Premium
Indian drugmakers Glenmark, Dr. Reddy’s Laboratories, and Emcure Pharma are in early talks to acquire the French drugmaker Sanofi’s flagship insulin brand Lantus, a media report said. Sanofi has slashed its asking price for the brand to Rs 2,000 crore from Rs 3,000 crore earlier, The Economic Times reported, citing people ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
